<?xml version="1.0" encoding="UTF-8"?>
<p id="Par4">Influenza vaccination is the primary method for preventing influenza and reducing the risk of severe outcomes. In the U.S., the Advisory Committee on Immunization Practices (ACIP) recommends annual influenza vaccination for all persons aged 6 months and older and prioritizes those at higher risk for influenza complications [
 <xref ref-type="bibr" rid="CR10">10</xref>]. High-risk groups include adults aged 
 <underline>&gt;</underline> 65 years [
 <xref ref-type="bibr" rid="CR11">11</xref>, 
 <xref ref-type="bibr" rid="CR12">12</xref>], children aged &lt; 5 years (particularly those aged &lt; 2 years) [
 <xref ref-type="bibr" rid="CR13">13</xref>, 
 <xref ref-type="bibr" rid="CR14">14</xref>], pregnant women (up to 2 weeks post-partum) [
 <xref ref-type="bibr" rid="CR15">15</xref>–
 <xref ref-type="bibr" rid="CR18">18</xref>], persons with certain chronic medical conditions, Native Americans/Alaska Natives,
 <xref ref-type="fn" rid="Fn1">1</xref> and residents of nursing homes and other long-term care facilities (Table 
 <xref rid="Tab2" ref-type="table">2</xref>). Studies have specifically highlighted that those with chronic pulmonary, cardiovascular, renal, hepatic, neurologic, hematologic or metabolic disorders, immunocompromised persons, children and adolescents receiving aspirin- or salicylate-containing medications and who might be at risk for experiencing Reye syndrome with influenza virus infection, and those who are extremely obese (BMI 
 <underline>&gt;</underline> 40) are at increased risk for influenza-related complications [
 <xref ref-type="bibr" rid="CR10">10</xref>, 
 <xref ref-type="bibr" rid="CR19">19</xref>–
 <xref ref-type="bibr" rid="CR23">23</xref>].
</p>
